Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. M. Riccio, R. W. Dal Negro, L. De Ferrari, C. Micheletto, G. W. Canonica, C. Folli, A. Chiappori (Genoa, Bussolengo, Italy). Anti-IgE and airway remodelling: Omalizumab affects reticular basement membrane thickness in severe persistent atopic asthma. Eur Respir J 2011; 38: Suppl. 55, 3848

Member's Comments

No comment yet.

Related content which might interest you: Noneosinophilic asthma in children: relation with airway remodelling Source: Eur Respir J 2011; 38: 575-583 Year: 2011 Effects of a 12-month course with omalizumab on basement membrane thickness in severe persistent atopic asthma Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Effects of a 12-month course with omalizumab on nasal polyps and basement membrane in severe atopic asthma Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Corticosteroid sensitivity, persistent airflow limitation and basement membrane thickening in children with asthma Source: Annual Congress 2008 - Treatment and outcome of childhood asthma: new perspectives Year: 2008 Reticular basement membrane (RBM) thickness, neutrophils and eosinophils in severe exacerbations of COPD and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 212s Year: 2002 Effects of add-on omalizumab therapy on airway wall thickening in severe persistent asthma Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011 Angiogenesis in the airway wall of atopic children without asthma Source: Eur Respir J 2006; 28: Suppl. 50, 599s Year: 2006 Parameters associated with persistent airflow obstruction in chronic severe asthma Source: Eur Respir J 2004; 24: 122-128 Year: 2004 Paracetamol and breakdown in epithelial barrier function in patients with asthma and atopic dermatitis Source: Annual Congress 2010 - Risk factors for allergic diseases in children Year: 2010 Bronchial wall inflammatory cells and signs of remodeling in COPD and asthma Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019 Osteopontin expression and relation to disease severity in human asthma Source: Eur Respir J 2011; 37: 331 Year: 2011 Osteopontin deficiency protects from airway remodelling and hyperresponsiveness in chronic asthma Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009 Mepolizumab improves small airway function in severe eosinophilic asthma Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions Year: 2018 Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Basement membrane thickness, eosinophilic inflammation and urinary LTE4 in patients with nasal polyps with or without bronchial asthma Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients Year: 2007 Increased arginase activity contributes to airway remodelling in chronic allergic asthma Source: Eur Respir J 2011; 38: 318-328 Year: 2011 Airways' remodelling contributes to abnormal lung function and bronchial hyperresponsiveness during clinical remission of atopic asthma Source: Eur Respir J 2001; 18: Suppl. 33, 4s Year: 2001 Subclinical small-airway dysfunction precedes the development of asthma in children with allergic rhinitis Source: International Congress 2017 – Small airways, long distances and large databases in paediatric asthma Year: 2017 Heterogeneous response of airway eosinophilia to biologics in severe asthma patients Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Subepithelial basement membrane thickness in bronchial asthma assessed by bronchoscopy Source: Eur Respir J 2005; 26: Suppl. 49, 118s Year: 2005